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Abstract
Genotype imputation methods are now being widely used in the analysis of genome-wide association studies. Most
imputation analyses to date have used the HapMap as a reference dataset, but new reference panels (such as controls
genotyped on multiple SNP chips and densely typed samples from the 1,000 Genomes Project) will soon allow a broader
range of SNPs to be imputed with higher accuracy, thereby increasing power. We describe a genotype imputation method
(IMPUTE version 2) that is designed to address the challenges presented by these new datasets. The main innovation of our
approach is a flexible modelling framework that increases accuracy and combines information across multiple reference
panels while remaining computationally feasible. We find that IMPUTE v2 attains higher accuracy than other methods when
the HapMap provides the sole reference panel, but that the size of the panel constrains the improvements that can be
made. We also find that imputation accuracy can be greatly enhanced by expanding the reference panel to contain
thousands of chromosomes and that IMPUTE v2 outperforms other methods in this setting at both rare and common SNPs,
with overall error rates that are 15%–20% lower than those of the closest competing method. One particularly challenging
aspect of next-generation association studies is to integrate information across multiple reference panels genotyped on
different sets of SNPs; we show that our approach to this problem has practical advantages over other suggested solutions.
Citation: Howie BN, Donnelly P, Marchini J (2009) A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association
Studies. PLoS Genet 5(6): e1000529. doi:10.1371/journal.pgen.1000529
Editor: Nicholas J. Schork, University of California San Diego and The Scripps Research Institute, United States of America
Received December 15, 2008; Accepted May 20, 2009; Published June 19, 2009
Copyright:  2009 Howie et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the
generation of the data is available from www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113. This research was
supported by funding and grants from the Wellcome Trust (PD), The Wolfson Foundation (PD), and a Wolfson-Royal Society Merit Award (PD). BNH was fundedb y
a National Science Foundation Graduate Research Fellowship and the Overseas Research Students Awards Scheme. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: marchini@stats.ox.ac.uk
¤ Current address: Department of Human Genetics, University of Chicago, Chicago, Illinois, United States of America
Introduction
Genome-wide association studies have identified many putative
disease susceptibility loci in recent years [1–3]. This approach to
studying disease has succeeded largely because of improved
catalogues of human genetic variation [4] and advances in
genotyping technology, but it has also been bolstered by the rise of
genotype imputation methods [5–8], which have allowed
researchers to tease increasingly subtle signals out of large and
complex genetic datasets [9,10].
Imputation methods work by combining a reference panel of
individuals genotyped at a dense set of polymorphic sites (usually
single-nucleotide polymorphisms, or ‘‘SNPs’’) with a study sample
collected from a genetically similar population and genotyped at a
subset of these sites. Figure 1 shows a schematic example of such a
dataset. Imputation methods predict unobserved genotypes in the
study sample by using a population genetic model to extrapolate
allelic correlations measured in the reference panel. The imputed
genotypes expand the set of SNPs that can be tested for
association, and this more comprehensive view of the genetic
variation in a study can enhance true association signals and
facilitate meta-analysis [9,10].
To date, most imputation analyses have used reference panels
composed of haplotypes from Phase II of the International
HapMap Project, together with study samples genotyped on
commercial genome-wide SNP arrays. Figure 1 depicts this
arrangement, which we call Scenario A. To understand how
imputation methods work in this setting, it helps to observe that
the SNPs exist in a natural hierarchy, such that they can be
partitioned into two disjoint sets: a set T that is typed in both the
study sample and the reference panel, and a set U that is untyped in
the study sample but typed in the reference panel. Informally,
most imputation methods phase the study genotypes at SNPs in T
and look for perfect or near matches between the resulting
haplotypes and the corresponding partial haplotypes in the
reference panel—haplotypes that match at SNPs in T are assumed
to also match at SNPs in U. This is the fundamental basis of
genotype imputation.
Several important points emerge from this description. First, the
accuracy with which the study haplotypes are phased at SNPs in T
should determine how well they can be matched to haplotypes in
the reference panel, which should in turn influence the accuracy of
imputation at SNPs in U. Second, accounting for the unknown
phase of the SNPs in T can be computationally expensive; if the
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able to impute genotypes at SNPs in U more quickly. Third, many
existing methods do not use all of the available information to
phase the study genotypes at SNPs in T. In principle, a phasing
algorithm should be able to ‘‘learn’’ about desirable phasing
configurations for a given study individual by pooling information
across the reference panel and all other individuals in the study,
and the phasing accuracy should increase with the sample size; in
standard practice, most imputation methods gain phasing
information about each study individual only from the reference
panel, and phasing accuracy does not depend on the size of the
study sample. (This description applies to imputation methods
based on hidden Markov models, or ‘‘HMMs’’ [6,11]; non-HMM
methods often discard other kinds of information.) The BEAGLE
imputation model [12,13] is one notable exception to this point,
and we discuss its alternative modeling strategy in detail in this
work.
We have developed a new algorithm that seeks to improve
imputation accuracy at untyped SNPs by improving phasing
accuracy at typed SNPs, building on the points raised above. Most
HMM-based imputation methods simultaneously estimate missing
genotypes and analytically integrate over the unknown phase of
SNPs in T. By contrast, we propose to alternately estimate
haplotypes at SNPs in T and impute alleles at SNPs in U, assuming
the haplotype guesses are correct. We account for the phasing
uncertainty in the data by iterating these steps in a Markov chain
Monte Carlo (MCMC) framework. Separating the phasing and
imputation steps allows us to focus more computational effort on
phasing and use more of the available information; the extra
computation used in this step is largely balanced by the quick
haploid imputation in the step that follows.
Figure 1. Schematic drawing of imputation Scenario A. In this drawing, haplotypes are represented as horizontal boxes containing 0’s and 1’s
(for alternate SNP alleles), and unphased genotypes are represented as rows of 0’s, 1’s, 2’s, and ?’s (where ‘1’ is the heterozygous state and ‘?’ denotes
a missing genotype). The SNPs (columns) in the dataset can be partitioned into two disjoint sets: a set T (blue) that is genotyped in all individuals and
a set U (green) that is genotyped only in the haploid reference panel. The goal of imputation in this scenario is to estimate the genotypes of SNPs in
set U in the study sample.
doi:10.1371/journal.pgen.1000529.g001
Author Summary
Large association studies have proven to be effective tools
for identifying parts of the genome that influence disease
risk and other heritable traits. So-called ‘‘genotype
imputation’’ methods form a cornerstone of modern
association studies: by extrapolating genetic correlations
from a densely characterized reference panel to a sparsely
typed study sample, such methods can estimate unob-
served genotypes with high accuracy, thereby increasing
the chances of finding true associations. To date, most
genome-wide imputation analyses have used reference
data from the International HapMap Project. While this
strategy has been successful, association studies in the
near future will also have access to additional reference
information, such as control sets genotyped on multiple
SNP chips and dense genome-wide haplotypes from the
1,000 Genomes Project. These new reference panels
should improve the quality and scope of imputation, but
they also present new methodological challenges. We
describe a genotype imputation method, IMPUTE version
2, that is designed to address these challenges in next-
generation association studies. We show that our method
can use a reference panel containing thousands of
chromosomes to attain higher accuracy than is possible
with the HapMap alone, and that our approach is more
accurate than competing methods on both current and
next-generation datasets. We also highlight the modeling
issues that arise in imputation datasets.
Imputation in Next-Generation Association Studies
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as we show in the Results section, but another major motivation of
this work is to extend IMPUTE [6] to handle ‘‘next-generation’’
association datasets. By this, we refer to studies in the near future
that will have access to additional reference data that could inform
imputation. Next-generation reference panels will present new
challenges for imputation, including larger sample sizes; unphased
and incomplete genotypes; and multiple reference panels contain-
ing different SNP sets. Our method aims to use the principles
outlined above to address these challenges and improve imputa-
tion accuracy in next-generation studies.
One new data configuration, which we call Scenario B and
explore in detail in the current study, is presented in Figure 2; we
will address other next-generation reference panels in the
Discussion. In Scenario B, there are different amounts of genotype
data in different cohorts of a study. For example, the Wellcome
Trust Case Control Consortium (WTCCC) is currently perform-
ing an association study in which 6,000 controls will be genotyped
on both the Affymetrix 6.0 and Illumina 1 M SNP chips, whereas
disease cohorts will be genotyped only on either the Affymetrix 6.0
chip or the Illumina 670 k chip. In other words, a large set of
controls will be genotyped at a subset of HapMap SNPs, and each
case cohort will be genotyped at a subset of the SNPs typed in the
controls. Published studies have already employed this design [14],
and it may become more prevalent in the future as common sets of
population controls become more widely available.
In Scenario B, the study individuals genotyped on a larger
number of SNPs can be used as an unphased, or ‘‘diploid’’,
reference panel for imputation in the remaining samples (which do
not necessarily have to be cases). As before, we approach such a
dataset by partitioning the SNPs into disjoint sets, named with
reference to the study sample: a set U1 that is untyped in the study
sample and typed only in the haploid reference panel, a set U2 that
is untyped in the study sample and typed in both the haploid and
diploid reference panels, and a set T that is typed in all samples.
We apply the same inference principles to Scenario B as to
Scenario A: at each MCMC iteration we phase all of the observed
data, pooling information across samples typed on common sets of
SNPs to estimate each haplotype pair, then perform haploid
imputation assuming that all of the haplotype guesses are correct.
One novelty of this scenario is that, at SNPs in U2, the reference
panel may contain thousands of chromosomes, in contrast to
HapMap Phase II panels that contain only 120–180 chromosomes
each. In principle, this added depth should improve imputation
accuracy at SNPs in U2, with notable gains at rare SNPs. The
latter point is especially relevant because rare SNPs are an
important source of power in imputation analyses [5,6]. Scenario
B also introduces the problem of multiple reference panels
Figure 2. Schematic drawing of imputation Scenario B. In this drawing, haplotypes are represented as horizontal boxes containing 0’s and 1’s
(for alternate SNP alleles), and unphased genotypes are represented as rows of 0’s, 1’s, 2’s, and ?’s (where ‘1’ is the heterozygous state and ‘?’ denotes
a missing genotype). The SNPs (columns) in the dataset can be partitioned into three disjoint sets: a set T (blue) that is genotyped in all individuals, a
set U2 (yellow) that is genotyped in both the haploid and diploid reference panels but not the study sample, and a set U1 (green) that is genotyped
only in the haploid reference panel. The goal of imputation in this scenario is to estimate the genotypes of SNPs in set U2 in the study sample and
SNPs in the set U1 in both the study sample and, if desired, the diploid reference panel.
doi:10.1371/journal.pgen.1000529.g002
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generation imputation datasets will follow this paradigm, which
presents modeling challenges that remain largely unexplored.
In the sections that follow, we describe the details of our new
method as applied to the scenarios in Figure 1 and Figure 2. We
then compare the method with other imputation approaches on
real datasets from the United Kingdom that emulate Scenarios A
and B. We show that our method can attain higher accuracy than
existing methods in Scenario A, but that the absolute gains are
small, which we attribute to the inherent limitations of a small set
of reference haplotypes. In an example of Scenario B, we
demonstrate that our method can use a large unphased reference
panel to achieve higher accuracy than imputation based on the
HapMap alone. We also show that our method can impute
genotypes more accurately than other sophisticated [11,13] and
simpler [15] methods applied to the same dataset, and that our
approach has higher sensitivity and specificity to detect copies of
the minor allele at rare SNPs. In addition, we present results that
highlight important practical advantages of our imputation
modeling strategy over the one used by BEAGLE.
We have implemented our new imputation method as an
update to our existing software package IMPUTE; the new
program is called ‘‘IMPUTE version 2’’ (IMPUTE v2). We refer
to our previously published method [6] as ‘‘IMPUTE version 1’’
(IMPUTE v1).
Materials and Methods
Software
IMPUTE v1 and IMPUTE v2 are freely available for academic
use from the website http://www.stats.ox.ac.uk/,marchini/
software/gwas/gwas.html
Scenario A
In Scenario A, IMPUTE v2 estimates marginal posterior
probabilities of missing genotypes by alternately phasing all of the
SNPs in T in the study sample (simultaneously imputing any
sporadically missing genotypes) and then imputing study genotypes
at the SNPs in U, conditional on the haplotype guesses from the
first step. To explain this process in more detail, we begin by
defining H
T,U
R , the set of known reference haplotypes at SNPs in T
and U (i.e., the entire reference panel); HT
R, the set of known
reference haplotypes at SNPs in T; and HT
S , the set of unobserved
study haplotypes at SNPs in T. If there are NS individuals in the
study sample, their haplotypes at SNPs in T can be represented as
HT
S ~ HT
S,1,...,HT
S,NS
no
, where HT
S,i is the haplotype pair for
study individual i.
The method begins by choosing initial guesses for the
haplotypes in HT
S – by default, we choose haplotypes that are
consistent with the observed genotype data but phased at random.
We then perform a number of MCMC iterations. Each iteration
updates every study individual i (in some arbitrary order) in two
steps:
1. Sample a new haplotype pair HT
S,i for individual i at SNPs in T.
This is accomplished by sampling from the conditional
distribution Pr HT
S,i
   GT
S,i,HT
S,({i),HT
R,r
  
, where GT
S,i is indi-
vidual i’s multilocus genotype at SNPs in T, HT
S, {i ðÞ contains
current-guess haplotypes at SNPs in T for all study individuals
except i, HT
R contains the reference panel haplotypes at SNPs
in T, and r is the fine-scale, population-scaled recombination
map for the region of interest. We describe this distribution
further below.
2. Impute new alleles (in two independent haploid steps) for SNPs
in U, conditional on HT
S,i, H
T,U
R , and r.
We typically run the method for a relatively small number of
burn-in iterations that invoke only the phasing step, followed by a
larger number of main iterations that include both steps and
contribute to the final imputation probabilities. We investigate the
convergence properties of the method in Text S1, Figure S1, and
Table S1.
In Step 1, the algorithm phases individual i’s observed genotype
GT
S,i by sampling from Pr HT
S,i
   GT
S,i,HT
S, {i ðÞ ,HT
R,r
  
. The model
we use to specify this conditional distribution is essentially the
same one used by IMPUTE v1 [6] – i.e., we use a hidden Markov
model that is based on an approximation to the coalescent-with-
recombination process [16]. This model views newly sampled
haplotypes as ‘‘imperfect mosaics’’ of haplotypes that have already
been observed. As with IMPUTE v1, we use an estimated fine-
scale recombination map [17] for SNP-to-SNP transition proba-
bilities and a result from population genetics theory [6] for
emission probabilities, which model historical mutation.
One difference between versions is that IMPUTE v1 analyti-
cally integrates over the unknown phase of the genotypes in the
study sample, whereas IMPUTE v2 uses Step 1 to integrate over
the space of phase reconstructions via Monte Carlo. This step is
accomplished for each individual by sampling a pair of paths
through the hidden states (haplotypes) of the model, then
probabilistically sampling a pair of haplotypes that is consistent
with the observed multilocus genotype. Path sampling is a
standard operation for HMMs, although in this case the
calculation burden can be reduced by careful inspection of the
equations for the HMM forward algorithm [11]. By default, the
state space of the model in Step 1 includes all of the known
haplotypes in HT
R and the current-guess haplotypes in HT
S, {i ðÞ .
The computational burden of these calculations (both in terms of
running time and memory usage) grows quadratically with the
number of haplotypes and linearly with the number of SNPs. We
later propose approximations to make these calculations more
tractable on large datasets.
In Step 2, the algorithm uses each of the haplotypes in HT
S,i
(which were sampled in Step 1) to impute new genotypes for SNPs
in U. The HMM state space for this step includes only the
reference panel haplotypes H
T,U
R . The imputation is accomplished
by running the forward-backward algorithm for HMMs indepen-
dently on each haplotype in HT
S,i and then analytically
determining the marginal posterior probabilities of the missing
alleles – this process is simply a haploid analogue of the one used
by IMPUTE v1. If we assume that both haplotypes were sampled
from a population that conforms to Hardy-Weinberg Equilibrium
(HWE), it is straightforward to convert these allelic probabilities to
genotypic probabilities for individual i. Across iterations, we can
then sum the posterior probabilities for each missing genotype as if
they were weighted counts; at the end of a run, the final Monte
Carlo posterior probabilities can be calculated by renormalizing
these sums. By contrast with Step 1, the computational burden of
these calculations grows only linearly with the number of
haplotypes. Consequently, Step 2 can usually avoid the approx-
imations needed to make Step 1 feasible, thereby allowing us to
make full use of even very large reference panels.
By using both the reference panel and the study sample to inform
phasing updates in Step 1, IMPUTE v2 uses more of the
information in the data than most comparable methods [6,11],
which typically account for phase uncertainty using only the
reference panel. At the same time, each iteration is relatively fast
because untyped SNPs are imputed in a haploid framework rather
Imputation in Next-Generation Association Studies
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used by other HMM methods. For example, one iteration of
IMPUTE v2 will typically finish faster and use less computer
memory than a run of IMPUTE v1 on the same dataset, although
IMPUTE v2 tends to be slower than IMPUTE v1 on the whole
since the new method requires multiple iterations. We explore the
computational burden of the method in detail in the Results section.
Scenario B
The structure of the dataset is more complex in this scenario
than in the previous one, but we follow the same basic principles of
imputation: phase the observed data, then impute alleles in each
haplotype separately, conditioning on as much observed data as
possible. Here, the goal of the phasing step is to end up with three
sets of haplotypes: H
T,U1,U2
HR , the known haploid reference panel
haplotypes at SNPs in T, U1, and U2; H
T,U2
DR , the unobserved
diploid reference panel haplotypes at SNPs in T and U2; and HT
S ,
the set of unobserved study haplotypes at SNPs in T. If there are
NDR individuals in the diploid reference panel, their haplotypes
can be represented as H
T,U2
DR ~ H
T,U2
DR,1,...,H
T,U2
DR,NDR
no
, where
H
T,U2
DR,i is the haplotype pair for diploid reference individual i.
The method begins by choosing initial guesses for the
haplotypes in H
T,U2
DR and HT
S – as before, we choose haplotypes
that are consistent with the observed genotype data but phased at
random. Each MCMC iteration now includes five steps. First, we
update every diploid reference individual i:
1. Sample a new haplotype pair H
T,U2
DR,i for individual i at SNPs in
T and U2. This is accomplished by sampling from the
conditional distribution Pr H
T,U2
DR,i
   G
T,U2
DR,i ,H
T,U2
DR, {i ðÞ ,H
T,U2
HR ,r
  
.
2. Impute new alleles (in two independent haploid steps) for SNPs
in U1, conditional on H
T,U2
DR,i , H
T,U1,U2
HR , and r.
In other words, we phase the observed data for diploid reference
individual i by pooling information across both reference panels,
then use these haplotypes in separate imputation steps based on
the haploid reference panel. Up to this point, we have simply
recapitulated Scenario A with different notation. Next, we update
every study individual i:
3. Sample a new haplotype pair HT
S,i for individual i at SNPs in T.
This is accomplished by sampling from the conditional
distribution Pr HT
S,i
   GT
S,i,HT
S, {i ðÞ ,HT
DR,HT
HR,r
  
.
4. Impute new alleles (in two independent haploid steps) for SNPs
in U2, conditional on HT
S,i, H
T,U2
DR , H
T,U2
HR , and r.
5. Impute new alleles (in two independent haploid steps) for SNPs
in U1, conditional on HT
S,i, H
T,U1
HR , and r.
As is Scenario A, burn-in iterations are used only for phasing
(Steps 1 and 3), while subsequent iterations cycle through all five
steps.
In this algorithm, each study individual gains phasing
information from all other individuals in the dataset, which can
lead to very accurate haplotype estimates at typed SNPs when the
total sample size is large. Once a study individual has sampled a
new pair of haplotypes, the imputation step is broken into two
parts: SNPs in U2 are imputed using information from both the
haploid and diploid reference panels (Step 4), and SNPs in U1 are
imputed using only the haploid reference panel (Step 5). This
modeling choice highlights a core principle of our inference
framework: we allow the method to naturally adapt to the amount
of information in the data by conditioning only on observed
genotypes, not imputed ones, at each step.
Choice of conditioning states
As noted above, the HMM calculations underpinning our
method require more running time and computer memory as
more haplotypes are added to the state space of the model. This
can be a problem for the phasing updates, whose computational
burden increases quadratically with the number of haplotypes
included in the calculation.
One solution, implemented in the phasing routine of the
MACH software, is to use only a random subset of the available
haplotypes for each update. For example, when sampling a new
haplotype pair from Pr HT
S,i
   GT
S,i,HT
S, {i ðÞ ,HT
R,r
  
in Step 1 of our
algorithm for Scenario A, we could use a random subset of k
haplotypes drawn from HT
S, {i ðÞ ,HT
R
no
to build the conditional
distribution, rather than the default approach of using all of the
haplotypes. This approximation to the model will generally
decrease accuracy, but it will also cause the computational burden
of the phasing updates to increase linearly (for fixed k), rather than
quadratically, with the number of chromosomes in the dataset.
We have developed another approximation that also constrains
phasing updates to condition on a subset of k haplotypes. Rather
than selecting haplotypes at random, our approach seeks to
identify the k haplotypes that are in some sense ‘‘closest’’ to the
haplotypes of the individual being updated. In genealogical terms,
this amounts to focusing attention on the parts of the underlying
tree where that individual’s haplotypes are located. The idea is
that haplotypes that reside nearby in the genealogical tree will the
most informative about the haplotypes of interest.
The structure of the underlying genealogical tree is usually
unknown (indeed, knowing the tree would essentially solve the
phasing problem), so we frame the list of the k closest haplotypes as
a random variable that gets updated for each individual at each
MCMC iteration. To sample a new phase configuration for
diploid individual i, we choose k conditioning states as follows: for
each available non-self haplotype (including current-guess haplo-
types for other diploid individuals), we calculate the Hamming
distance to each of individual i’s current-guess haplotypes and
store the minimum of these two distances. Then, we use the k
haplotypes with the smallest distances to build the HMM and
sample a new pair of haplotypes for individual i.
The transition and emission probabilities of our model [6]
depend explicitly on k. The intuition is that, as k gets larger, jumps
between different copied haplotypes should become less likely and
those haplotypes should be copied with higher fidelity; this is
because a chromosome will coalesce faster into a larger genealogy,
leaving less time for recombination and mutation events to occur
[18]. The underlying theory assumes that the haplotypes in
question were sampled randomly from a population, which is
clearly not the case when we select k haplotypes in the manner
described above. To account for the fact that these haplotypes will
find common ancestors (going backwards in genealogical time)
more quickly than would k haplotypes chosen at random, we
replace k with the total number of available haplotypes when specifying
the HMM parameters for a phasing update.
We refer to this approximation as informed selection of
conditioning states. While this method is built upon genealogical
intuitions, we emphasize that no explicit genealogies are
constructed in our inference scheme. One way of understanding
our approach is by comparison to the phasing method of Kong et
al. [19]. Their method uses rule-based techniques to phase
putative ‘‘unrelateds’’ by identifying long stretches of identity-by-
state (IBS) sharing between individuals, under the assumption that
such sharing is caused by recent common descent. Our Hamming
distance metric can be viewed as a way of identifying near-IBS
Imputation in Next-Generation Association Studies
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closely related individuals in a model-based way rather than
seeking perfect IBS matching between specific individuals. In this
sense, our approximation can be viewed as a flexible middle
ground between full conditional modeling (which uses all of the
available haplotypes to phase an individual) and the Kong et al.
method (which may use only a small fraction of the available
haplotypes to phase an individual).
In our experience, imputation based on this informed method for
choosing conditioning states is only trivially slower than otherwise
identical analyses based on random state selection, effectively
because the common HMM calculations take much longer than
calculatingallpairwiseHammingdistancesintheinformedmethod.
At the same time, the informed method can generally achieve the
same phasing accuracy as the random method using many fewer
states, or higher accuracy for a fixed number of states (data not
shown). This is a major advantage because it is computationally
expensivetoaddstatestothemodel(i.e.,toincreasek).Wetherefore
focus on the informed state selection method in this study, with the
random method used only during MCMC burn-in, although both
approaches are implemented in our software. We conduct an
exploration of the parameter settings under informed selection,
including the dependence of imputation accuracy on k, in Text S1,
where we also discuss potential limitations of the informed state
selection scheme.
Modeling strategies for imputation datasets
In order to understand the modeling choices underlying our new
imputation algorithm, it is crucial to consider the statistical issues
that arise in imputationdatasets. For simplicity, we will discuss these
issues in the context of Scenario A, although we will also extend
them to Scenario B in the Results section. Fundamentally,
imputation is very similar to phasing, so it is no surprise that most
imputation algorithms are based on population genetic models that
were originally used in phasing methods. The most important
distinction between phasing and imputation datasets is that the
latter include large proportions of systematically missing genotypes.
Large amounts of missing data greatly increase the space of
possible outcomes, and most phasing algorithms are not able to
explore this space efficiently enough to be useful for inference in
large studies. A standard way to overcome this problem with
HMMs [6,11] is to make the approximation that, conditional on
the reference panel, each study individual’s multilocus genotype is
independent of the genotypes for the rest of the study sample. This
transforms the inference problem into a separate imputation step
for each study individual, with each step involving only a small
proportion of missing data since the reference panel is assumed to
be missing few, if any, genotypes.
In motivating our new imputation methodology, we pointed out
that modeling the study individuals independently, rather than
jointly, sacrifices phasing accuracy at typed SNPs; this led us to
propose a hybrid approach that models the study haplotypes
jointly at typed SNPs but independently at untyped SNPs. We
made the latter choice partly to improve efficiency – it is fast to
impute untyped alleles independently for different haplotypes,
which allows us to use all of the information in large reference
panels – but also because of the intuition that there is little to be
gained from jointly modeling the study sample at untyped SNPs.
By contrast, the recently published BEAGLE [13] imputation
approach fits a full joint model to all individuals at all SNPs. To
overcome the difficulties caused by the large space of possible
genotype configurations, BEAGLE initializes its model using a few
ad-hoc burn-in iterations in which genotype imputation is driven
primarily by the reference panel. The intuition is that this burn-in
periodwillhelpthemodelreachaplausiblepart ofparameterspace,
which can be used as a starting point for fitting a full joint model.
This alternative modeling strategy raises the question of
whether, and to what extent, it is advantageous to model the
study sample jointly at untyped SNPs. One argument [20] holds
that there is no point in jointly modeling such SNPs because all of
the linkage disequilibrium information needed to impute them is
contained in the reference panel. A counterargument is that, as
with any statistical missing data problem, the ‘‘correct’’ inference
approach is to create a joint model of all observed and missing
data. We have found that a full joint model may indeed improve
accuracy on small, contrived imputation datasets (data not shown),
and this leads us to believe that joint modeling could theoretically
increase accuracy in more realistic datasets.
However, a more salient question is whether there is any useful
information to be gained from jointly modeling untyped SNPs, and
whether this information can be obtained witha reasonable amount
of computational effort. Most imputation methods, including our
new algorithm, implicitly assume that such information is not worth
pursuing, whereas BEAGLE assumes that it is. We explore this
question further in the sections that follow.
Results
To test our new imputation method, we compared it with
established methods on realistic datasets that fit the two scenarios
described above.
Scenario A
As an example of Scenario A, we used the 120 HapMap CEU
parental haplotypes as a reference panel to impute genotypes in
the WTCCC 1958 Birth Cohort (58 C) controls [1]. The 58 C
samples were genotyped on the Affymetrix 500 K SNP chip, and
the data were subjected to the SNP and sample filters specified in
the WTCCC study [1]. Of the 1,502 58 C individuals, 1,407 were
also genotyped on the Illumina 550 K chip, and 1,377 passed
filtering in both datasets. We supplied only the latter set of
individuals to the imputation methods, and we asked them to
impute the 22,270 CEU HapMap SNPs on chromosome 10 that
were represented on the Illumina chip but not the Affymetrix chip.
We then used the imputed Illumina genotypes to evaluate the
success of imputation based on the Affymetrix data.
Program settings. We used the following methods to
perform the imputation: IMPUTE v1.0; MACH v0.1.10 with
analytical (‘‘mle’’) imputation, where the model parameters were
selected by running the ‘‘greedy’’ algorithm for 100 iterations on a
random subset of 500 58 C samples, as suggested in the online
tutorial that accompanies the software (http://www.sph.umich.
edu/csg/abecasis/mach/tour/imputation.html); fastPHASE [11]
v1.3.2 with 20 and 30 clusters (K=20 and K=30, in separate
runs), 15 starts of the expectation-maximization (EM) algorithm to
estimate model parameters, and 35 iterations per EM start (this
version of fastPHASE automatically fits the clustering model to the
reference panel and then imputes each study individual separately,
conditional on the fitted model); BEAGLE v3.0.2 on default
settings and with 50 iterations (rather than the default 10); and
IMPUTE v2.0 with 40 and 80 conditioning states used for diploid
updates at typed SNPs (k=40 and k=80, in separate runs) and
120 conditioning states (i.e., the full HapMap CEU panel) used for
all haploid updates. We ran IMPUTE v2 with 10 burn-in
iterations followed by 20 additional iterations. The first 3 burn-in
iterations used random conditioning states for phasing updates,
and all subsequent iterations used informed conditioning states.
We discuss the motivations for these settings in Text S1.
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analysis because the Genetic Association Information Network
(GAIN) Imputation Working Group is planning to publish a
similar comparison using a broad cross-section of methods; our
goal here is mainly to benchmark a new method. In order to speed
up the analysis via our parallel computing facilities, we split
chromosome 10 into 20 non-overlapping analysis chunks. Each
imputation run spanned 7 Mb, with an additional 250 kb buffer
on either side that was used for inference but omitted from the
results – this buffer guards against a deterioration of imputation
quality near the chunk edges. We ran every algorithm using the
same analysis chunks.
Accuracy comparison. The results of this analysis are shown
in Figure 3. The x-axes in this figure display the discordance
between imputed genotype calls and observed Illumina calls,
which is a surrogate for imputation error rate; the y-axes display
the percentage of genotypes for which no call was made. Each
method’s line is formed by considering several different calling
thresholds for imputation posterior probabilities. For example, a
certain number of maximum posterior probabilities will exceed a
threshold of 0.9, and among these we can ask what percentage of
the best-guess imputed genotypes disagree with the Illumina
genotypes. This yields an x-coordinate, and the y-coordinate is
simply the percentage of all imputed genotypes for which no
posterior probability exceeds the threshold. We generated the lines
on the plots by repeating these calculations for calling thresholds
ranging from 0.33 to 0.99 for each method.
On these plots, lines that are below and to the left of other lines
are more desirable. One interpretation is that, for a given level of
missing data, an imputation method with a line further to the left
has lower discordance with the external genotypes. Such plots
allow us to evaluate competing methods in a more nuanced way
than just looking at best-guess genotypes (which is equivalent to
setting a single calling threshold of 1/3). We strongly emphasize,
however, that the point of this exercise is not to determine an
‘‘optimal’’ calling threshold and use this to make hard calls of
imputed genotypes for downstream analyses. Imputation results
inherently contain more uncertainty than experimental genotype
calls, and a host of methods have been developed to appropriately
take this uncertainty into account when doing things like
association testing [6]. Such methods are implemented in our
freely available association testing software, SNPTEST.
Figure 3A shows the full results of this comparison. The curves
are difficult to distinguish in this plot, so Figure 3B and 3C
magnifies either end of the range to highlight the salient features.
The grid lines in all three panels are shown at the same vertices to
help convey the degree of magnification. The results can also be
summarized by the best-guess error rate for each method (x-
intercept on the plots): BEAGLE (default), 6.33%; BEAGLE (50
iterations), 6.24%; fastPHASE (K=20), 6.07%; fastPHASE
(K=30), 5.92%; IMPUTE v1, 5.42%; IMPUTE v2 (k=40),
5.23%; IMPUTE v2 (k=80), 5.16%; MACH, 5.46%. Figure 3
shows that IMPUTE v1 (blue) achieved error rates that were
consistently, if only slightly, lower than those of MACH (cyan)
across the range of calling thresholds, and that both methods
yielded lower error rates than fastPHASE (black) and BEAGLE
(green). The IMPUTE v2 run with k=40 (solid red line) attained
similar accuracy to IMPUTE v1 at stringent calling thresholds
(Figure 3B), although IMPUTE v2 gained a slight advantage at
more lenient thresholds (Figure 3C). The IMPUTE v2 run with
k=80 (dotted red line) showed a small but consistent improvement
over both IMPUTE v1 and the other IMPUTE v2 run.
Computational requirements. To describe the relative
computational burdens of these methods, we re-ran each
program on a more limited dataset on a single Linux server,
which had four dual-core Intel Xeon processors (running at
2.33 GHz, with a 6.1 MB cache, and using a 64-bit architecture)
and a total of 8 GB of RAM. Specifically, we repeated the analysis
for the 4
th,8
th,1 2
th, and 16
th chunks, each of which encompasses a
7.5 Mb region of chromosome 10 (centered, respectively, at
positions 22.22 Mb, 50.22 Mb, 78.22 Mb, and 106.22 Mb in
NCBI Build 35 coordinates). The average running times and
memory requirements for these analyses are shown in Table 1.
Table 1 shows that IMPUTE v1 was the fastest of the methods
considered here, followed by BEAGLE (default), MACH, IMPUTE
v2 (k=40), BEAGLE (50 iterations), fastPHASE (K=20), IMPUTE
v2 (k=80), and fastPHASE (K=30). Conversely, fastPHASE
required the least computer memory, followed by MACH,
IMPUTE v2, IMPUTE v1, and BEAGLE. Note that, while
IMPUTE v2 with k=40 took about six times as long as IMPUTE
v1,itneededlessthan16%oftheRAM;thisismainlyaconsequence
of modeling SNPs in U as haploid in version 2, as opposed to diploid
in version 1. We also note that both fastPHASE and MACH spent
most of their running time fitting their models to the HapMap, and
that both methods could probably decrease running times (via more
lenient settings) without sacrificing much accuracy.
Scenario B
We simulated Scenario B by modifying the WTCCC 58 C
dataset as follows: First, we integrated the genotypes from the two
SNP chips for the 1,377 shared 58 C individuals (see Text S1 for
details), yielding a consensus set of 44,875 SNPs. Next, we split the
58 C samples into two groups: a diploid reference panel of 918
individuals (2/3 of the dataset) and a study sample of 459
individuals. To complete the reference panel, we added 120
haplotypes from the HapMap Phase II CEU data. We then created
two Scenario B study sample datasets by masking the genotypes of
SNPs unique to each chip in turn; there were 18,489 such SNPs on
the Affymetrix chip and 22,219 such SNPs on the Illumina chip.
Modeling considerations. A full representation of Scenario
B would include all HapMap SNPs that are polymorphic in the
CEU panel. There were 138,592 such SNPs in our dataset, with
44,875 of these belonging to set U2 and the remaining 93,717 to set
U1. This data structure is problematic for most imputation methods
because their modeling strategies are premised on a single reference
panel in which most genotypes have been observed (i.e., some
version of Scenario A). If the data from both reference panels in
Scenario B were combined into a single panel, many reference
SNPs (those in U1) would be missing large proportions of their
genotypes, which could substantially decrease imputation accuracy
in the study sample. Ad-hoc modifications of these approaches are
not attractive either. For example, it would be possible for such
methods to impute SNPs in U1 in the diploid reference panel and
then combine the observed and imputed genotypes to impute SNPs
in U1 and U2 in the study sample, but failing to account for the
uncertainty in the imputed reference genotypes would probably
lead to overconfident and lower-quality inferences. Alternatively, it
would be possible to perform separate imputation runs on the SNPs
in {U1,T} and the SNPs in {U2,T}, but this approach is neither
elegant nor convenient in a large association study.
To our knowledge, BEAGLE is the only method other than
ours that has proposed a strategy for overcoming these difficulties.
(This strategy is not discussed in the paper [13], but it is detailed in
the documentation accompanying the BEAGLE v3.0 software.)
When BEAGLE encounters multiple reference panels, as in
Scenario B, it simply downweights the less complete panels during
the burn-in stage of its model-fitting procedure. Specifically, every
individual in the dataset is assigned a weight that reflects the
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more missing data get lower weights, and therefore have less
influence on the early steps of the model-fitting algorithm. This
detail aside, BEAGLE still fits a joint model to the complete
dataset in Scenario B, in contrast to the IMPUTE v2 approach of
modeling the observed data jointly but the missing data
independently.
In light of these considerations, we decided to create two
versions of our Scenario B dataset: one that includes the full set of
HapMap SNPs, and one in which the HapMap dataset is restricted
to SNPs that were genotyped on at least one of the chips (i.e., in
which all SNPs in U1 have been removed). We used the latter
dataset to broaden the range of methods that could be included in
the comparison (at the cost of removing some of the complexity of
Scenario B), and we used the former dataset to evaluate BEAGLE
and IMPUTE v2 in a more realistic setting.
Program settings. In the restricted dataset, we used
IMPUTE v1.0, IMPUTE v2.0, BEAGLE v3.0.2, fastPHASE
v1.3.2, and PLINK [15] v1.03 to impute each chip’s masked
genotypes from the other chip’s study sample genotypes and the
Figure 3. Percentage discordance versus percentage missing genotypes for Scenario A dataset. (A) Full range of results, corresponding
to calling thresholds from 0.33 to 0.99. (B) Magnified results for calling thresholds near 0.99. (C) Magnified results for calling thresholds near 0.33.
doi:10.1371/journal.pgen.1000529.g003
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used the 918 diploid individuals and the 120 HapMap CEU
haplotypes as an expanded reference panel for imputation, while
IMPUTE v1 was provided with only the HapMap reference panel.
We ran IMPUTE v1, BEAGLE, and PLINK on their default
imputation settings, and we also performed separate BEAGLE
runs with 50 iterations (rather than the default 10). We ran
fastPHASE with 20 and 30 clusters (K=20 and K=30, in separate
runs), 15 starts of the EM algorithm to estimate model parameters,
and 35 iterations per EM start. As in Scenario A, we first fit the
fastPHASE clustering model to the reference data, then instructed
the software to impute each of the 459 study individuals
independently, conditional on the fitted model. Finally, we set
IMPUTE v2 to use 40 and 80 conditioning states (k=40 and
k=80, in separate runs) for phasing updates in both diploid panels
and 1,956 reference panel states (26918+120) for haploid
imputation updates in the study sample. As before, we ran the
algorithm for 30 MCMC iterations with the first 10 discarded as
burn-in, and we specified that the algorithm should choose
random conditioning states for phasing updates in the first 3
iterations and informed conditioning states thereafter.
On the full Scenario B dataset, we ran BEAGLE and IMPUTE
v2 using the faster settings described above: 10 iterations for
BEAGLE and k=40 for IMPUTE v2. For each SNP that was not
typed in the study sample, IMPUTE v2 used all observed
reference panel chromosomes in each imputation step (1,956 states
at SNPs in U2 and 120 states at SNPs in U1).
Accuracy comparison on restricted dataset. The results
of our restricted Scenario B comparison are shown in Figure 4,
using the same discordance vs. missing genotype percentage
format as Figure 3. Note that each panel in this figure follows a
different scale. The top two panels (Figure 4A and 4B) share a
common set of grid lines, and the bottom two panels (Figure 4C
and 4D) share a finer set of grid lines. We omitted the results from
the BEAGLE run with 50 iterations since they were only trivially
better than the results based on default settings.
Figure 4A shows the results for all Illumina-only SNPs imputed
from Affymetrix genotypes, and Figure 4B shows the equivalent
results for Affymetrix-only SNPs imputed from Illumina geno-
types. One striking difference between these plots is that the
imputations based on Illumina genotypes (Figure 4B) are generally
more accurate. There are a number of possible explanations for
this trend: the Illumina chip has a higher SNP density, and
imputation generally improves as more SNPs are observed; the
Affymetrix chip contains a larger proportion of rare SNPs, which
are easier to impute on the whole, as we discuss below; and, while
the Illumina SNPs were specifically chosen to predict, or ‘‘tag’’,
many of the common Affymetrix SNPs via the HapMap, the
reverse is not true.
Regardless, one trend within Figure 4A and 4B is clear: with an
expanded reference panel containing nearly 2,000 chromosomes,
it is possible to improve imputation accuracy substantially over
what is attainable with 120 chromosomes. For example, the
IMPUTE v2 runs with k=40 (solid red line) achieved best-guess
discordance rates of 3.40% and 0.86% in Figure 4A and 4B,
respectively, whereas the rates for IMPUTE v1 (which had access
to only the HapMap reference panel; blue line) were 5.42% and
1.62%. BEAGLE (green), fastPHASE (black), and IMPUTE v2
(red) were all able to increase accuracy with the expanded
reference panel, but the improvements for fastPHASE were
smaller. BEAGLE (solid green line) and IMPUTE v2 with k=40
(solid red line) yielded similar results: for BEAGLE, the best-guess
discordance rates in Figure 4A and 4B were 3.46% and 0.93%.
For IMPUTE v2, increasing the number of conditioning states
used for phasing updates to k=80 further reduced the discordance
rates to 3.07% and 0.78%.
Unlike the other imputation methods with access to the
expanded reference panel, PLINK achieved lower accuracy than
IMPUTE v1; in Figure 4A and 4B, PLINK’s best-guess
discordances were 7.83% and 2.45%. We tried varying PLINK’s
settings from their defaults, including settings that were much
more computationally rigorous, but these additional runs led to
negligible improvements. PLINK is faster than the other methods
considered here, which are all based on HMMs, but it also uses a
simpler population genetics model. The multinomial haplotype
frequency model that PLINK uses for imputation has fared poorly
in recent comparisons of phasing methods [21]; its role in this
analysis was to see if any accuracy is lost by using a simpler method
to speed up imputation in a large and complex dataset.
Our results suggest that the model used by PLINK (which also
underpins other imputation methods [7]) may be a liability in a
dataset in which a large proportion of genotypes, including those
in the reference panel, are unphased. However, we also note that
PLINK’s imputation functionality is still in beta testing. A recent
study of Type 1 Diabetes [14] used a similar method to impute
genotypes in a Scenario B dataset. Like PLINK, this method
defines a multimarker tag for each SNP to be imputed, although in
this case there is no phasing model since the tagging is based on
correlations between unphased genotypes. It is not clear how this
method would have fared in our comparison, but its similarities
with PLINK imply that future studies might be better off using
more sophisticated imputation methods.
Figure 4C and 4D mirrors Figure 4A and 4B, respectively, but
these results are restricted to imputed SNPs with minor allele
frequencies (MAFs) less than 5%—Figure 4C is based on 1,113
SNPs and Figure 4D is based on 1,979 SNPs. The same relative
patterns remain, although the discordance and missing data
percentages are lower because it is easier to guess most of the
genotypes correctly and with high confidence at a rare SNP than a
common one, simply because most genotypes at a rare SNP will be
homozygous for the common allele. Among the most accurate
methods, the best-guess discordances based on Affymetrix
genotypes (Figure 4C) were 1.01% (IMPUTE v2, k=40), 0.84%
(IMPUTE v2, k=80), and 0.97% (BEAGLE), as compared to
1.73% for HapMap-based imputation with IMPUTE v1; the
Table 1. Running times and memory requirements for
various algorithms in Scenario A.
Method
Avg. running
time (min)
Avg. required
RAM (MB)
BEAGLE 56 3100
BEAGLE (50iter) 392 3200
fastPHASE (K=20) 397 8
fastPHASE (K=30) 855 16
IMPUTE v1 43 1000
IMPUTE v2 (k=40) 270 155
IMPUTE v2 (k=80) 505 180
MACH 105 80
Running times are in minutes (min) and RAM requirements are in megabytes
(MB). Each entry in the table is an average across four runs on different 7.5 Mb
regions of chromosome 10. Each analysis included a reference panel of 120
chromosomes (CEU HapMap) and a study sample of 1,377 individuals
genotyped on the Affymetrix 500 K SNP chip.
doi:10.1371/journal.pgen.1000529.t001
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(IMPUTE v2, k=40), 0.38% (IMPUTE v2, k=80), and 0.46%
(BEAGLE), as compared to 0.93% for IMPUTE v1.
Accuracy comparison on full dataset. The results of our
full Scenario B comparison are shown in Figure 5 in two panels that
mirror Figure 4A and 4B. Although this dataset contains a large
number of HapMap-only SNPs that were imputed here but not in
the restricted dataset, we calculated discordance only at masked
chipSNPsinthestudysample,sothecurvesinFigure4andFigure5
are based on exactly the same sets of masked genotypes. There are
four curvesineachpanel:IMPUTEv2inthe fullScenario B dataset
(k=40; dashed red line); BEAGLE in the full dataset (default
settings; dashed green line); BEAGLE in the restricted dataset
(default settings; solid green line); and IMPUTE v1 in the restricted
dataset (solid blue line). The first two curves (dashed lines) are the
main focus of this comparison, and the latter two curves (solid lines)
are carried over from Figure 4 for reference.
One important point about this figure is that the IMPUTE v2
curve is in exactly the same place as in Figure 4. It follows from
our modeling approach that simply adding SNPs to the set U1,a s
Figure 4. Percentage discordance versus percentage missing genotypes for restricted Scenario B dataset. (A) Results for masked
Illumina genotypes imputed from Affymetrix genotypes in the study sample. (B) Results for masked Affymetrix genotypes imputed from Illumina
genotypes in the study sample. (C) Results for masked Illumina genotypes (SNPs with MAF,5% only) imputed from Affymetrix genotypes in the
study sample. (D) Results for masked Affymetrix genotypes (SNPs with MAF,5% only) imputed from Illumina genotypes in the study sample.
doi:10.1371/journal.pgen.1000529.g004
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Conversely, Figure 5 shows that adding SNPs to U1 actually makes
BEAGLE’s imputation results worse at SNPs in U2: between the
restricted and full datasets, the best-guess discordance increased
from 3.46% to 4.01% in panel A and from 0.93% to 1.04% in
panel B. We observed a similar decline in accuracy at rare SNPs,
which are not shown separately in Figure 5. Hence, in the full
Scenario B dataset, which we regard as a more realistic application
of these methods, IMPUTE v2 achieves a best-guess discordance
that is 15–18% smaller than BEAGLE’s. In the Discussion, we
propose an explanation for the change in BEAGLE’s results
between the full and restricted datasets.
A major goal of performing imputation in Scenario B (and
extensions thereof) is to simultaneously use all available reference
data in an integrated modeling framework. As such, it is also
important to assess the quality of imputation at SNPs in U1 (i.e.,
HapMap-only SNPs) in this context. To do so, we created a
modified version of the full Scenario B dataset with observed
Illumina genotypes in the study sample. We masked every 25
th
Illumina SNP in both the study sample and the diploid reference
panel, then ran BEAGLE and IMPUTE v2 as before. We
repeated these steps for each of the 24 other possible sets of
masked SNPs (i.e., after shifting the starting index), so that every
Illumina SNP was masked and imputed exactly once.
Across these imputation runs, the best-guess discordance at
masked SNPs in U1 was 2.87% for IMPUTE v2 and 3.60% for
BEAGLE – i.e., the discordance for IMPUTE v2 was 20% smaller
than the discordance for BEAGLE.
Detecting minor allele copies at rare SNPs. While
Figure 4 confirms that a large reference panel can improve
imputation accuracy at rare and common SNPs alike, it is
instructive to examine where the gains at rare SNPs are made. To
evaluate this question, we took the results from Figure 4C and 4D
and classified the kinds of errors made by each method’s best-guess
imputations (i.e., at a calling threshold of 1/3). We focused
primarily on the ability of each method to detect copies of the
minor allele. This is clearly an important quantity, but it is
obscured by gross measures of accuracy, which are inherently
dominated by homozygote-common genotypes at rare SNPs. We
examined two classifications of erroneous minor allele calls: false
positives (homozygous common called as heterozygous) and false
negatives (heterozygous called as homozygous common). The
results are shown in Table 2, where the false positive and false
negative rates are expressed as percentages of the total number of
homozygous common and heterozygous genotypes, respectively.
Several insights emerge from this table. First, IMPUTE v2 was
consistently among the best methods for reducing both false
negatives and false positives, suggesting that our new approach is
generally more accurate than others at imputing rare SNPs.
Second, while most methods were much more likely to make false
negative calls than false positive calls, IMPUTE v1 was relatively
Figure 5. Percentage discordance versus percentage missing genotypes for full Scenario B dataset. (A) Results for masked Illumina
genotypes imputed from Affymetrix genotypes in the study sample. (B) Results for masked Affymetrix genotypes imputed from Illumina genotypes in
the study sample. Solid lines were obtained from the restricted Scenario B dataset (Figure 4) and are shown for reference; dashed lines were obtained
from the full Scenario B dataset.
doi:10.1371/journal.pgen.1000529.g005
Table 2. False negative (FN) and false positive (FP) minor
allele call rates at rare SNPs (MAF,5%) in Scenario B.
Method Affymetrix 500 K data Illumina 550 K data
FN calls (%) FP calls (%) FN calls (%) FP calls (%)
BEAGLE 12.81 0.30 6.75 0.17
fastPHASE (K=20) 21.12 0.28 11.07 0.15
fastPHASE (K=30) 19.46 0.27 9.77 0.13
IMPUTE v1* 14.52 0.79 10.23 0.34
IMPUTE v2 (k=40) 12.86 0.15 6.81 0.07
IMPUTE v2 (k=80) 9.66 0.15 4.90 0.08
PLINK 32.79 0.53 25.63 0.40
The two columns on the left show results for Illumina-only genotypes imputed
from Affymetrix 500 K data in the study sample, and the two columns on the
right show results for Affymetrix-only genotypes imputed from Illumina 550 K
data. The FN rates are expressed as percentages of genotypes that are truly
heterozygous and the FP rates as percentages of genotypes that are truly
homozygous common.
*Unlike the other methods, IMPUTE v1 was not provided with the diploid
reference panel. Consequently, these numbers are based on using a reference
panel of 120 chromosomes to impute a study sample of 459 individuals.
doi:10.1371/journal.pgen.1000529.t002
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with the use of a smaller reference panel, which will tend to
overestimate the population frequencies of rare alleles. At the same
time, IMPUTE v1 missed fewer true heterozygote calls than did
fastPHASE or PLINK, despite using a much smaller reference
panel. This tendency for fastPHASE and PLINK to mistake rare
heterozygotes as homozygous for the major allele is the main
factor separating these methods from IMPUTE v2 and BEAGLE
in Figure 4C and 4D. Conversely, BEAGLE and IMPUTE v2
with k=40 showed similar false negative rates, but IMPUTE v2
made half as many false positive rare allele calls.
Putting these pieces together, it appears that IMPUTE v2
achieves higher accuracy than other methods at rare SNPs
because it has both high sensitivity and high specificity for
detecting rare alleles. These results show the strength of using a
large reference panel for imputation, and of our particular
approach to performing inference in that setting.
Computational requirements. As in Scenario A, we re-ran
all programs on a single Linux server to assess their computational
burdens in Scenario B. We used the same server and analysis
chunks as before; the average running times and memory
requirements across these four 7.5 Mb regions of chromosome
10 are shown in Table 3. (These numbers were averaged across
both the masked Affymetrix and masked Illumina datasets, so
eight runs contributed to each table entry.) Numbers in
parentheses refer to the full Scenario B dataset, and all other
numbers refer to the restricted dataset. Note that IMPUTE v1 was
run on a version of the dataset that did not include the diploid
reference panel.
PLINK was the fastest of these methods, followed by IMPUTE
v1, BEAGLE, IMPUTE v2, and fastPHASE. PLINK also
required the least RAM, followed by fastPHASE, IMPUTE v2,
IMPUTE v1, and BEAGLE. While BEAGLE was quite fast, it
also required more than ten times as much RAM as any other
method (at least 2.5 GB per 7.5 Mb region of the genome).
BEAGLE includes an option to decrease memory usage, but this
would come at the cost of increased running time.
We emphasize that IMPUTE v1 was among the fastest methods
in this comparison only because it was assigned a much smaller
problem: its reference panel contained 120 phased haplotypes,
while every other method confronted a panel with 1,956
chromosomes, most of which were unphased. Using the
knowledge that IMPUTE v1’s computational burden grows
quadratically with the number of chromosomes in the reference
panel, we can project that it would have required over
1,300 minutes and 69,000 MB of RAM to run the program on
a single 7.5 Mb analysis chunk with a reference panel of that size
(which would also have needed to be phased ahead of time). This
highlights a major advantage of our new modeling strategy:
whereas IMPUTE v1 becomes computationally intractable as the
reference panel grows, IMPUTE v2 remains competitive (both in
computational burden and imputation accuracy) while allowing
more flexibility (such as multiple, unphased, and/or incomplete
reference panels).
Another advantage of our approach can be seen by comparing
the running times of the restricted and full datasets for BEAGLE
and IMPUTE v2. The average BEAGLE run took 3.3 times
longer in the full dataset than in the restricted dataset, whereas the
IMPUTE v2 running time increased by factor of just 1.1. For
comparison, the total number of SNPs in the dataset increased by
a factor of 3.1. This contrast between the methods arises from the
way they model SNPs in U1: IMPUTE v2 models only the
reference panel at such SNPs, whereas BEAGLE tries to model all
individuals in the dataset. We regard the full dataset as a more
realistic application of these methods, so we believe that the
parenthetical running times in Table 2 offer the best comparison
between BEAGLE and IMPUTE v2.
Discussion
In this study we introduced a new method for genotype
imputation in large association studies. Our method, IMPUTE
version 2, follows a flexible inference framework that uses more of
the information in the data than many comparable methods,
thereby improving accuracy, while remaining computationally
tractable on large datasets. This approach is well-suited to the
kinds of datasets that will become available in next-generation
association studies: it can handle large reference panels, including
ones with unphased and incomplete genotypes, and it can also
integrate multiple referencepanels containingdifferent sets ofSNPs.
Scenario A
The observation that IMPUTE v2 can achieve lower error rates
than IMPUTE v1 in Scenario A validates our new approach. At
the same time, the absolute improvement is small, as can be seen
in Figure 3 by comparing the separation between IMPUTE v1
and v2 with the separation between IMPUTE v1 and MACH,
which typically yield very similar results in our experience. We
have also performed separate experiments in which IMPUTE v2
achieves much higher phasing accuracy than IMPUTE v1 at SNPs
in T, but where the improvements in HapMap-based imputation
of SNPs in U remain modest (data not shown). We suggest that this
disconnect between phasing accuracy and imputation accuracy is
caused by the inherent limitations of a small reference panel; in
other words, we posit that existing models would not attain
substantially lower imputation error rates with the current
HapMap panel even if we knew the phase of the study genotypes perfectly.
In the wake of these results, we suspect that the accuracy
improvement of IMPUTE v2 over IMPUTE v1 is not practically
Table 3. Running times and memory requirements for
various algorithms in Scenario B.
Method
Avg. running
time (min)
Avg. required
RAM (MB)
BEAGLE 21 (70) 2500 (3200)
fastPHASE (K=20) 530 12
fastPHASE (K=30) 1100 20
IMPUTE v1* 5 260
IMPUTE v2 (k=40) 409 (450) 80 (190)
IMPUTE v2 (k=80) 790 120
PLINK 1.5 8
Running times are in minutes (min) and RAM requirements are in megabytes
(MB). Each entry in the table is an average across eight runs, including four runs
on different 7.5 Mb regions of chromosome 10 for study samples with either
Affymetrix-only or Illumina-only SNPs masked. Each analysis included a haploid
reference panel of 120 chromosomes (CEU HapMap), a diploid reference panel
of 1836 chromosomes, and a study sample of 459 individuals. Numbers in
parentheses represent analyses that included all SNPs that are polymorphic in
the HapMap CEU panel; for the rest of the analyses, only SNPs that were
genotyped on either the Affymetrix 500 K or Illumina 550 K chip were included
in the HapMap dataset.
*Unlike the other methods, IMPUTE v1 was not provided with the diploid
reference panel. Consequently, these numbers are based on using a reference
panel of 120 chromosomes to impute a study sample of 459 individuals.
doi:10.1371/journal.pgen.1000529.t003
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However, given that IMPUTE v1’s computational requirements
scale quadratically with the number of chromosomes in the
reference panel while IMPUTE v2’s requirements grow linearly,
the newer version may become more computationally favorable as
baseline reference panels grow in the future. For example,
expanding the HapMap reference panel in this study to 800
chromosomes (which is roughly the size anticipated for each panel
in the 1,000 Genomes Project) would lead to similar running times
for both versions of IMPUTE, but version 2 would need only 2%
of the computer memory required by version 1. At the same time,
IMPUTE v2 would probably achieve higher accuracy, and its
computational advantages over IMPUTE v1 would continue to
grow with larger reference panels.
Scenario B
In our Scenario B dataset, we demonstrated that an expanded
reference panel containing thousands of chromosomes can greatly
improve accuracy over what is possible based on the HapMap
alone, although these gains are limited to the subset of HapMap
SNPs that are included on multiple genotyping chips. This finding
is consistent with the conclusions of the recent BEAGLE paper
[13]. IMPUTE v2 was consistently among the most accurate
methods we considered. For example, IMPUTE v2 attained best-
guess error rates that were 15–20% lower than those of its closest
competitor (BEAGLE) in a realistic representation of Scenario B.
Rare SNPs are of particular interest because of an increasing
awareness that such SNPs may underlie common, complex
diseases, and because imputation methods gain the most power
over tagging approaches at such SNPs [6,11]. Expanded reference
panels ought to allow rare SNPs to be imputed much more
accurately than they can be with the HapMap panel, and our
method is able to exploit this information more effectively than
competing methods. Relative to IMPUTE v1 (which had access to
only the HapMap reference panel) and BEAGLE, the main
improvement of IMPUTE v2 is to increase specificity by cutting
down on false positive heterozygous calls; relative to fastPHASE
and PLINK, the main improvement is to increase sensitivity by
cutting down on false negative heterozygous calls.
Modeling issues in imputation datasets
Throughout this study we have touched on the fundamental
modeling difficulties that arise in imputation datasets, and we have
discussed various strategies that have been proposed to solve these
problems. In particular, we have contrasted the BEAGLE
approach of full joint modeling with the IMPUTE v2 approach,
which phases the observed data jointly but imputes the missing
alleles in different haplotypes independently.
Based on the results seen here and elsewhere [13], we claim that
BEAGLE gains very little useful information through joint
modeling of entire imputation datasets. Consider these lines of
evidence:
1. In our Scenario B comparison, BEAGLE’s accuracy at SNPs in
U2 actually decreased when SNPs were added to U1. This is
highly counterintuitive: it is hard to explain why adding
HapMap-only SNPs to a dataset, without changing any of the
data in the rest of a region, should have a noticeable effect on
the imputation of SNPs in an expanded reference panel, let
alone a negative effect.
2. Browning and Browning (2009) observed that BEAGLE
attained better accuracy by subdividing a study sample and
fitting the model separately to each subsample (along with the
complete reference panel) than by simply fitting the model to
the entire dataset – indeed, this subdividing strategy is now
recommended as standard practice by the authors. The
benefits of subdividing the sample were attributed to ‘‘model
averaging’’, but that is not an apt description of the process
since each individual in the dataset is subjected to only a single
model fit. Some model fits are probably better than others due
to the stochastic nature of the algorithm, but some are also
worse, so there is no reason to expect systematic improvements
from this strategy if the model is working properly.
3. Browning and Browning (2009) also observed that, for a fixed
study sample of 188 individuals, BEAGLE’s accuracy consis-
tently improved relative to that of IMPUTE v1 as the size of
the reference panel increased. No mechanistic rationale was
provided to explain this trend.
The first two points document strange behavior of the BEAGLE
method: apparently, adding data – whether in the form of
additional SNPs or additional individuals in the study sample –
can cause BEAGLE’s imputation accuracy to decrease. More
specifically, it seems that increasing the proportion of missing data harms
BEAGLE’s inferences. This suggests an explanation for the third
point above: as the reference panel grew and the study sample
remained fixed, the total proportion of missing genotypes in the
sample decreased, thereby generating datasets that were relatively
less harmful to BEAGLE.
In our view, these disparate observations point to a single
underlying cause: joint modeling of untyped SNPs is generally
ineffective, and it grows progressively worse as the space of missing
genotypes expands. BEAGLE was competitive in our analyses, so
its modeling strategy may have some merit, but it is also possible
that BEAGLE’s success came in spite of the joint modeling
framework, not because of it. A better alternative might be to
embed the same clustering model in a framework like the ones
used by fastPHASE or IMPUTE v2. We suggest that further
scrutiny be applied before a full joint model is used in general
applications. Comparisons like ours, and others [13], are
necessarily restricted to artificially small datasets, but we have
shown that these ‘‘toy’’ datasets can mask problems that might
occur in more realistic settings, which will often include larger
amounts of missing data. In practice, the accuracy levels and
running times achieved by BEAGLE in our study may represent
best-case scenarios rather than standard results.
These considerations apply to imputation datasets in general,
but it is particularly interesting to examine them in the context of
multiple reference panels genotyped on different sets of SNPs.
BEAGLE’s joint approach to such datasets is flexible, but we have
seen that it can lose accuracy when certain kinds of new data are
added. Conversely, IMPUTE v2’s multi-panel modeling strategy
responds intuitively to new sources of information like additional
individuals or SNPs. This property makes it easy to predict how
IMPUTE v2 will perform in larger and more complex datasets
than the ones used here, whereas the same cannot necessarily be
said for BEAGLE.
More broadly, we believe that any imputation algorithm should
strive to incorporate as much of the available reference
information as possible while remaining easy to use. For example,
in Scenario B it is desirable to simultaneously impute the SNPs in
the expanded panel (to improve accuracy) and the SNPs
represented only in the HapMap (to maintain genomic coverage).
IMPUTE v2 provides an integrated framework for handling this
kind of problem: it is flexible enough to handle numerous
variations of Scenarios A and B, yet it remains tractable by
focusing computational effort on the parts of the dataset that are
most informative.
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The expanded reference panel we considered was constituted by
controls genotyped on multiple SNP chips, but other kinds of new
reference panels will also become available in the near future. For
example, the HapMap Project has recently augmented its Phase II
data with additional samples from both the original HapMap
locations and new locations aimed at capturing more human
genetic diversity. These samples have all been genotyped on
multiple, largely non-overlapping SNP chips, and could be used
for imputation in the same way as the controls in our Scenario B.
In addition, the 1,000 Genomes project is currently pursuing
whole-genome sequencing of hundreds of individuals sampled
from broad geographic regions in Africa, East Asia, and Europe.
One aim of the project is to generate high-quality haplotypes for
these individuals, including near-complete coverage of SNPs with
population MAFs of 1% or more. This resource will increase the
utility of imputation approaches by expanding both the number of
chromosomes in the reference set and the number of SNPs that
can be imputed.
Our method is well-suited to this kind of dataset: in addition to
its ability to accurately impute rare SNPs, which will constitute
most of the new variants in the 1,000 Genomes data, IMPUTE v2
expends relatively little computational effort on haploid imputa-
tion steps. This means that, for a given SNP chip typed in a given
study sample, doubling the number of untyped variants in a
phased reference panel will increase the computational burden of
imputation by a factor of less than two. By contrast, other
imputation methods (such as IMPUTE v1, BEAGLE, and
fastPHASE) would slow down by a factor of at least two.
One major use of our new method (and of imputation methods
generally) will be to facilitate meta-analyses [9,10], which combine
samples from studies of similar diseases to increase the chances of
detecting low-penetrance risk alleles. For this application, we
might expect to repeat Scenario B for a number of different study
samples genotyped on different SNP chips. Rather than re-phase
the diploid reference panel for each study sample, we can save
time by simply storing the posterior samples from a single run of
phasing the reference panel, then read these sampled haplotypes
from memory when processing each study sample. This function-
ality is implemented in our software.
IMPUTE v2 is already fast enough to use in large association
studies, but we also have plans to make it faster. We believe that
the software can gain some speed simply by optimizing the code,
but we also have plans to implement an analytical speed-up for the
HMM forward-backward calculations [22] that may further
decrease running times by a factor of five or so.
Finally, while we described our imputation approach in terms of
two specific scenarios involving the HapMap, it could in fact be
generalized to include any number of reference panels of any type
(phased/unphased, complete/incomplete) so long as their SNP
sets follow a hierarchy such as the ones laid out in Figure 1 and
Figure 2. We envision that IMPUTE v2 will be used in a variety of
situations. For example, it may soon become standard practice to
combine the HapMap Phase II and Phase III datasets to create a
compound reference panel like the one in Scenario B, except with
all of the reference data phased. Another plausible situation is the
version of Scenario B that we described, in which a large set of
controls is used to impute genotypes in cases; we discuss some
concerns about association testing in this setting in Text S1 and
Figure S2. IMPUTE v2 will also be applied in populations beyond
the UK controls used in this study, and we expect that its
performance will follow trends much like those observed for
similar imputation methods [23,24].
Our modeling strategy is flexible and fast, and it is general
enough that it could be adopted by other imputation methods. We
believe that this intuitive way of thinking about imputation
datasets will benefit next-generation association studies, and that
IMPUTE v2 will prove to be a useful tool for finding subtle signals
of association.
Supporting Information
Figure S1 Percentage discordance between best-guess imputed
and observed Illumina genotypes for various parameter settings of
IMPUTE v2. These results were obtained from a 2 Mb region of
chromosome 10 in the Scenario B dataset.
Found at: doi:10.1371/journal.pgen.1000529.s001 (0.27 MB TIF)
Figure S2 Expected versus observed p-values for additive
association tests between the 58 C and UKBS control groups,
where the UKBS genotypes have been imputed from 58 C
genotypes. (A) p-p plot for common (MAF$5%) SNPs. (B) p-p plot
for rare SNPs. The 95% concentration band is shown in grey, and
the y=x line is shown in red.
Found at: doi:10.1371/journal.pgen.1000529.s002 (0.13 MB TIF)
Table S1 Convergence statistics for various parameter settings of
IMPUTE v2. For each combination of burn-in and main
iterations, the number shown is the percentage of imputed
genotypes for which the R convergence statistic was greater than
1.02 across 10 independent runs of the algorithm. The results are
stratified into genotypes at 100 common SNPs (left) and genotypes
at 24 rare SNPs (right); for rare SNPs, only genotypes that include
the minor allele were used in the calculations. These results were
obtained from a 2 Mb region of chromosome 10 in our Scenario B
dataset, using IMPUTE v2 with k=30 (results with k=100 were
similar).
Found at: doi:10.1371/journal.pgen.1000529.s003 (0.03 MB PDF)
Text S1 Performance of IMPUTE v2 under various parameter
settings; Convergence of IMPUTE v2 algorithm; Limits of
informed conditioning approximation; Integrating genotypes from
two SNP chips; Association testing of cases imputed from controls.
Found at: doi:10.1371/journal.pgen.1000529.s004 (0.28 MB PDF)
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